Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 18Other hematologic neoplasm 3Dermatologic 3Thoracic 2Plasma cell 2Head & Neck 2Gynecologic 2Myeloid 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Multiple Myeloma 27Hodgkin Disease 3Breast Neoplasms 3Recurrence 2Ovarian Neoplasms 2Neoplasms 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lung Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Waldenstrom Macroglobulinemia 1Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Thrombocytosis 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Smoldering Multiple Myeloma 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Chronic 1

Interventions

Cyclophosphamide 71fludarabine phosphate 67Peripheral Blood Stem Cell Transplantation 60Mycophenolic Acid 52Whole-Body Irradiation 42Cyclosporine 39Tacrolimus 38Busulfan 35Antilymphocyte Serum 35Filgrastim 29Radiotherapy 27Methotrexate 24Melphalan 20Cord Blood Stem Cell Transplantation 19Methylprednisolone 17Etoposide 15fludarabine 11Therapeutics 10Flow Cytometry 10Sirolimus 9Psychiatric Rehabilitation 8Granulocyte Colony-Stimulating Factor 8Cytarabine 8sargramostim 7Rituximab 7Polymerase Chain Reaction 7Bortezomib 7Transplantation 6Alemtuzumab 6Thiotepa 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma, Follicular × pembrolizumab × Plasma cell × Clear all
NCT02362035 2026-05-13

KEYNOTE145

Acerta Pharma BV

Phase 1/2 Completed
161 enrolled 29 charts
LymphoidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

NCT01953692 2021-08-04

MK-3475-013

Merck Sharp & Dohme LLC

Phase 1 Completed
197 enrolled 52 charts
LymphoidMyeloidPlasma cell

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡